Literature DB >> 798197

Hypolipidaemic action of gemfibrozil in adult nephrotics.

A Eisalo, V Manninen, M Mälkönen, B Kuhlbäck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 798197      PMCID: PMC1864013     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  12 in total

1.  Effects of infusions of serum albumin on serum lipids and lipoproteins in nephrosis.

Authors:  J H BAXTER; H C GOODMAN; J C ALLEN
Journal:  J Clin Invest       Date:  1961-03       Impact factor: 14.808

2.  Experimental reconstruction of metabolic pattern of lipid nephrosis: key role of hepatic protein synthesis in hyperlipemia.

Authors:  J B MARSH; D L DRABKIN
Journal:  Metabolism       Date:  1960-10       Impact factor: 8.694

3.  Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia.

Authors:  J F Bridgman; S M Rosen; J M Thorp
Journal:  Lancet       Date:  1972-09-09       Impact factor: 79.321

4.  Hyperlipoproteinaemias in nephrotic syndrome.

Authors:  J S Chopra; N P Mallick
Journal:  Lancet       Date:  1971-02-13       Impact factor: 79.321

5.  Ischaemic heart-disease as a complication of nephrotic syndrome.

Authors:  G M Berlyne; N P Mallick
Journal:  Lancet       Date:  1969-08-23       Impact factor: 79.321

6.  Hyperlipoproteinemia in patients with chronic renal failure.

Authors:  M Brons; N C Christensen; M Horder
Journal:  Acta Med Scand       Date:  1972 Jul-Aug

7.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

8.  Letter: Serum-H.D.L. in atherosclerotic heart-disease.

Authors: 
Journal:  Lancet       Date:  1976-05-08       Impact factor: 79.321

9.  Lipoprotein profiles in adult nephrotics.

Authors:  S R Newmark; C F Anderson; J V Donadio; R D Ellefson
Journal:  Mayo Clin Proc       Date:  1975-07       Impact factor: 7.616

10.  Clofibrate-induced muscle damage in patients with chronic renal failure.

Authors:  A M Pierides; F Alvarez-Ude; D N Kerr
Journal:  Lancet       Date:  1975-12-27       Impact factor: 79.321

View more
  2 in total

1.  Gemfibrozil absorption and elimination in kidney and liver disease.

Authors:  H Knauf; E U Kölle; E Mutschler
Journal:  Klin Wochenschr       Date:  1990-07-05

2.  Mechanism of action of gemfibrozil on lipoprotein metabolism.

Authors:  K Saku; P S Gartside; B A Hynd; M L Kashyap
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.